Plus Therapeutics Stock (NASDAQ: PSTV) stock price, news, charts, stock research, profile.
Open | $1.740 |
Close | $1.750 |
Volume / Avg. | 7.102K / 29.700K |
Day Range | 1.740 - 1.857 |
52 Wk Range | 0.969 - 5.100 |
Market Cap | $8.274M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 1.08% |
Days to Cover | 1.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Plus Therapeutics (NASDAQ: PSTV) through any online brokerage.
Other companies in Plus Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX), Longeveron (NASDAQ:LGVN) and Portage Biotech (NASDAQ:PRTG).
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on Tuesday, August 15, 2023. The analyst firm set a price target for 8.00 expecting PSTV to rise to within 12 months (a possible 357.14% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $1.75 last updated April 16, 2024 at 2:09 PM EDT.
There are no upcoming dividends for Plus Therapeutics.
Plus Therapeutics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Plus Therapeutics.
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.